Sequana Medical N.V.
SEQUA.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €1 | €1 | €0 |
| % Growth | -85.1% | -22.8% | 149% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€2 | €1 | €1 | €0 |
| % Margin | -2,092.5% | 77% | 77.8% | 79.3% |
| R&D Expenses | €2 | €5 | €8 | €6 |
| G&A Expenses | €6 | €7 | €7 | €5 |
| SG&A Expenses | €16 | €20 | €17 | €14 |
| Sales & Mktg Exp. | €1 | €2 | €2 | €2 |
| Other Operating Expenses | €1 | €0 | €4 | €4 |
| Operating Expenses | €19 | €26 | €29 | €24 |
| Operating Income | -€19 | -€29 | -€28 | -€23 |
| % Margin | -17,647.2% | -4,141.1% | -3,044.9% | -6,113.2% |
| Other Income/Exp. Net | -€26 | -€3 | -€2 | -€1 |
| Pre-Tax Income | -€44 | -€32 | -€30 | -€23 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | -€45 | -€33 | -€31 | -€24 |
| % Margin | -42,126.4% | -4,572.4% | -3,334.1% | -6,373.8% |
| EPS | -1.22 | -1.22 | -1.35 | -1.3 |
| % Growth | 0% | 9.6% | -3.8% | – |
| EPS Diluted | -1.22 | -1.22 | -1.35 | -1.3 |
| Weighted Avg Shares Out | 37 | 27 | 23 | 18 |
| Weighted Avg Shares Out Dil | 37 | 27 | 23 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €1 | €0 | €0 |
| Interest Expense | €26 | €4 | €1 | €1 |
| Depreciation & Amortization | €1 | €0 | €1 | €0 |
| EBITDA | -€17 | -€29 | -€29 | -€22 |
| % Margin | -16,409.4% | -4,091.3% | -3,164% | -6,002.9% |